Clinical, genetic and experimental studies of the Brooke–Spiegler (CYLD) skin tumor syndrome
Journal of Plastic Surgery and Hand Surgery · 04.03.2019 · 53 (2) · 71-75
DOI: 10.1080/2000656x.2018.1547736 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Plastic Surgery and Hand Surgery, online erschienen am 24.01.2019. Verfasst von Mattias K Andersson und 3 weiteren Autor:innen. Beteiligte Einrichtung: a Sahlgrenska Cancer Center, Department of Pathology , University of Gothenburg , Gothenburg , Sweden. Hauptthemen laut MEDLINE: Heterografts, Neoplasms, Experimental. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 13 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Swedish Cancer Society, BioCARE – a National Strategic Cancer Research Program, Assar Gabrielsson Cancer Research Foundation.
Abstract (Originalsprache)
Brooke-Spiegler syndrome (BSS; a.k.a. tuban tumor syndrome) is an autosomal dominant inherited skin disorder caused by germline mutations in the CYLD tumor suppressor gene. BSS is characterized by multiple skin adnexal tumors, mainly cylindromas and spiradenomas on the head and neck. The tumors are often severely disfiguring and require repeated surgical interventions. Here, we describe a four-generation BSS-family with a novel germline c.1613_1614delGC CYLD mutation that introduces a premature STOP codon predicted to result in a truncated, inactivated CYLD protein. In addition, we present a pilot study describing establishment of the first patient-derived xenografts (PDXs) from cutaneous CYLD-defective cylindromas. Fresh tumor tissues from cylindromas were transplanted into immunocompromised mice to generate PDXs. One xenograft showed progressive tumor growth after 3 months whereas the others remained unchanged in size during the 6 months study period. Histopathological and immunohistochemical analyses of the PDXs revealed that they recapitulate the histological and molecular features of their respective primary tumors, including expression of NTRK3 and the oncogenic driver MYB. In summary, we present the first preclinical BSS-model that morphologically and genetically recapitulates human CYLD-defective cylindromas. This model will be useful for preclinical therapeutic drug testing and for further studies of the molecular pathogenesis of inherited cylindromas.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- a Sahlgrenska Cancer Center, Department of Pathology , University of Gothenburg , Gothenburg , Sweden.
- b Department of Plastic Surgery , University of Gothenburg , Gothenburg , Sweden.
- c Sahlgrenska Cancer Center, Department of Surgery , University of Gothenburg , Gothenburg , Sweden.
Förderung
- Swedish Cancer Society, BioCARE – a National Strategic Cancer Research Program
- Assar Gabrielsson Cancer Research Foundation
Zitieren
APA
Andersson, M. K., Kölby, L., Nilsson, J. A., & Stenman, G. (2019). Clinical, genetic and experimental studies of the Brooke–Spiegler (CYLD) skin tumor syndrome. Journal of Plastic Surgery and Hand Surgery, 53(2), 71-75. https://doi.org/10.1080/2000656x.2018.1547736
Vancouver
Andersson MK, Kölby L, Nilsson JA, Stenman G. Clinical, genetic and experimental studies of the Brooke–Spiegler (CYLD) skin tumor syndrome. Journal of Plastic Surgery and Hand Surgery. 2019;53(2):71-75. doi:10.1080/2000656x.2018.1547736
BibTeX
@article{Andersson2019,
author = {Andersson, Mattias K and Kölby, Lars and Nilsson, Jonas A and Stenman, Göran},
title = {Clinical, genetic and experimental studies of the Brooke–Spiegler (CYLD) skin tumor syndrome},
journal = {Journal of Plastic Surgery and Hand Surgery},
year = {2019},
volume = {53},
number = {2},
pages = {71--75},
doi = {10.1080/2000656x.2018.1547736}
}
EUVIMED